gemox
Showing 1 - 8 of 8
Intrahepatic Cholangiocarcinoma Trial in Tianjin (Sintilimab, IBI305, GEMOX)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Sintilimab
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 22, 2022
Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)
Active, not recruiting
- Advanced Primary Liver Cancer
- Advanced Biliary Tract Carcinoma
- SHR-1210
- +3 more
-
Zhengzhou, Henan, China
- +1 more
Apr 26, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Belgium, Italy, Spain (BI 836826, GemOx, Rituximab)
Completed
- Lymphoma, Large B-Cell, Diffuse
- BI 836826
- +2 more
-
Hasselt, Belgium
- +6 more
Mar 13, 2019
Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer Trial in Shanghai (biological test, GEMOX, Cetuximab)
Unknown status
- Cholangiocarcinoma of the Extrahepatic Bile Duct
- Gallbladder Cancer
- biological test
- +8 more
-
Shanghai, Shanghai, ChinaXinhua Hospital
May 4, 2018
Advanced Urothelial Carcinoma Trial in Daegu, Daejeon, Seoul (GCb, GemOx)
Unknown status
- Advanced Urothelial Carcinoma
- GCb
- GemOx
-
Daegu, Korea, Republic of
- +4 more
Sep 22, 2014
Prostate Cancer Trial in Seoul (GEMOX)
Completed
- Prostate Cancer
- GEMOX
-
Seoul, Korea, Republic ofAsan Medical Center
Nov 30, 2013